XML 12 R4.htm IDEA: XBRL DOCUMENT v3.22.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenues $ 1,023,315 $ 90,793
Operating expenses    
General and administrative 209,932 5,503
Rent expense 90,031 1,500
Management fees 30,000
Professional fees 49,587 36
Salaries and wages 436,825 12,852
Depreciation expense 132,000 32,125
Total operating expenses 948,375 52,016
Operating Income 74,940 38,777
Other (expense) income    
Other income 10,018
Warrants exercised (90,000)
Fair value of warrants granted to convertible note holders (976,788)
Penalty on convertible notes (9,240)
Interest expense (80,768) (137,677)
Amortization of debt discount (252,832) (502,677)
Derivative liability movement 197,476 (611,059)
Foreign exchange movements (95,556) (79,492)
Net loss before taxation (146,722) (2,368,156)
Taxation (18,263)
Net loss (164,985) (2,368,156)
Net income attributable to non-controlling interest (9,462)
Net loss attributable to Ethema Health Corporation Stockholders’ (174,447) (2,368,156)
Preferred stock dividend (24,613) (30,847)
Net loss available to common shareholders of Ethema Health Corporation (199,060) (2,399,003)
Foreign currency translation adjustment 34,517 29,606
Total comprehensive loss $ (164,543) $ (2,369,397)
Basic and diluted loss per common share $ (0.00) $ (0.00)
Weighted average common shares outstanding – Basic and diluted 3,630,720,472 2,143,692,378